β-Glucan extracts from the same edible shiitake mushroom Lentinus edodes produce differential in-vitro immunomodulatory and pulmonary cytoprotective effects — Implications for coronavirus disease (COVID-19) immunotherapies
Open Access
- 1 August 2020
- journal article
- research article
- Published by Elsevier in Science of The Total Environment
- Vol. 732, 139330
Abstract
No abstract availableKeywords
Funding Information
- Health Research Board
This publication has 33 references indexed in Scilit:
- Determination of Glucan Contents in the Fruiting Bodies and Mycelia of Lentinula edodes CultivarsMycobiology, 2014
- Advances in lentinan: Isolation, structure, chain conformation and bioactivitiesFood Hydrocolloids, 2011
- Studies on the relationship between pulsed UV light irradiation and the simultaneous occurrence of molecular and cellular damage in clinically-relevant Candida albicansJournal of Microbiological Methods, 2011
- Oxidative Stress, Plasminogen Activator Inhibitor 1, and Lung FibrosisAntioxidants & Redox Signaling, 2008
- An integrated model of the recognition of Candida albicans by the innate immune systemNature Reviews Microbiology, 2008
- Oxidative stress and steroid resistance in asthma and COPD: pharmacological manipulation of HDAC-2 as a therapeutic strategyExpert Opinion on Therapeutic Targets, 2007
- Medicinal Mushrooms and Cancer Therapy: translating a traditional practice into Western medicinePerspectives in Biology and Medicine, 2006
- Characterization and immunomodulating activities of polysaccharide from Lentinus edodesInternational Immunopharmacology, 2005
- Immune recognition of fungal β-glucansCellular Microbiology, 2005
- Dectin-1 uses novel mechanisms for yeast phagocytosis in macrophagesBlood, 2004